Cited by 1,828Substance Abuse Treatment and OutcomesAlcohol Consumption and Health EffectsAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Naltrexone in the Treatment of Alcohol Dependence

Volpicelli, Joseph R.·1992·Archives of General Psychiatry

DOI 10.1001/archpsyc.1992.01820110040006

Open this paper in CoChat — free account

Abstract

Seventy male alcohol-dependent patients participated in a 12-week, double-blind, placebo-controlled trial of naltrexone hydrochloride (50 mg/d) as an adjunct to treatment following alcohol detoxification. Subjects taking naltrexone reported significantly less alcohol craving and days in which any alcohol was consumed. During the 12-week study, only 23% of the naltrexone-treated subjects met the criteria for a relapse, whereas 54.3% of the placebo-treated subjects relapsed. The primary effect of naltrexone was seen in patients who drank any alcohol while attending outpatient treatment. Nineteen (95%) of the 20 placebo-treated patients relapsed after they sampled alcohol, while only eight (50%) of 16 naltrexone-treated patients exposed to alcohol met relapse criteria. Naltrexone was not associated with mood changes or other psychiatric symptoms. Significant side effects (nausea) occurred in two naltrexone-treated subjects, and one naltrexone-treated subject complained of increased pain from arthritis. These results suggest that naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse.

Integrity signals

Registry

Crossref · 10.1001/archpsyc.1992.01820110040006

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H., & Covi, L. (1974) · Behavioral Science · doi:10.1002/bs.3830190102 · Cited by 4,604
Survival Analysis
Miller, R. G. (1981) · Cited by 3,336
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Alteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
The Effectiveness of Alcoholism Treatment
Miller, W. R., & Hester, R. K. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2191-0_7 · Cited by 276
The serotonin uptake inhibitor citalopram attenuates ethanol intake
Naranjo, C. A., Sellers, E. M., Sullivan, J. T., Woodley-Remus, D., Kadlec, K. E., & Sykora, K. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.27 · Cited by 236
Naltrexone blocks the post-shock increase of ethanol consumption
Volpicelli, J. R., Davis, M. A., & Olgin, J. E. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90601-6 · Cited by 187
Self-citation
Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey
Myers, R. D., Borg, S., & Mossberg, R. (1986) · Alcohol · doi:10.1016/0741-8329(86)90058-3 · Cited by 167
Lithium Treatment of Depressed and Nondepressed Alcoholics
Dorus, W. (1989) · JAMA · doi:10.1001/jama.1989.03430120100029 · Cited by 164
Oral ethanol self-administration in the rat: Effect of naloxone
Samson, H. H., & Doyle, T. F. (1985) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(85)90491-5 · Cited by 162

Show all 23 references

Sorted by citations

Items 501–600 of 1,004

Physicians in Long-Term Recovery Who Are Members of Alcoholics Anonymous
Galanter, M. S., Dermatis, H., Stanievich, J. F., & Santucci, C. (2013) · American Journal on Addictions · doi:10.1111/j.1521-0391.2013.12051.x · Cited by 61
Ethanol actions on the ventral tegmental area: novel potential targets on reward pathway neurons
You, C., Vandegrift, B. J., & Brodie, M. S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4875-y · Cited by 67
Anticraving therapy for alcohol use disorder: A clinical review
Shen, W. W. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12028 · Cited by 61
Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis
Palpacuer, C., Hammas, K., Duprez, R., Laviolle, B., Ioannidis, J. P. A., & Naudet, F. (2019) · BMC Medicine · doi:10.1186/s12916-019-1409-3 · Cited by 62
Animal Models of Motivation for Drinking in Rodents with a Focus on Opioid Receptor Neuropharmacology
Koob, G. F., Roberts, A. J., Kieffer, B. L., Heyser, C. J., Katner, S. N., Ciccocioppo, R., & Weiss, F. (2002) · Springer eBooks · doi:10.1007/0-306-47939-7_19 · Cited by 61
The Patient Recovering from Alcohol or Drug Addiction: Special Issues for the Anesthesiologist
May, J. A., White, H. C., Leonard-White, A., Warltier, D. C., & Pagel, P. S. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200106000-00050 · Cited by 60
Spending on substance abuse treatment: how much is enough?
Meara, E. R., & Frank, R. G. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01227.x · Cited by 61
-HYDROXYBUTYRIC ACID REDUCING EFFECT ON ETHANOL INTAKE: EVIDENCE IN FAVOUR OF A SUBSTITUTION MECHANISM
Agabio, R., Colombo, G., Loche, A., Lobina, C., Pani, M., Reali, R., & GESSA, G. L. (1998) · Alcohol and Alcoholism · doi:10.1093/alcalc/33.5.465 · Cited by 61
Nano-Level Detection of Naltrexone Hydrochloride in Its Pharmaceutical Preparation at Au Microelectrode in Flowing Solutions by Fast Fourier Transforms Continuous Cyclic Voltammetry as a Novel Detector
Norouzi, P., Ganjali, M. R., Zare, M., & Mohammadi, A. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20851 · Cited by 61
THE LONG-TERM COST-EFFECTIVENESS OF IMPROVING ALCOHOL ABSTINENCE WITH ADJUVANT ACAMPROSATE
Palmer, A. J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.5.478 · Cited by 61
Further Validation of the Obsessive-Compulsive Drinking Scale (OCDS): Relationship to Alcoholism Severity
Moak, D. H., Anton, R. F., & Latham, P. K. (1998) · American Journal on Addictions · doi:10.3109/10550499809034708 · Cited by 61
Regression to the mean in substance use disorder treatment research
Finney, J. W. (2008) · Addiction · doi:10.1111/j.1360-0443.2007.02032.x · Cited by 78
Naltrexone augmentation in OCD: A double-blind placebo-controlled cross-over study
Amiaz, R., Fostick, L., Gershon, A. A., & Zohar, J. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.01.006 · Cited by 61
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
Chick, J., Lehert, P., & Landron, F. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174017 · Cited by 60
Effectiveness of Naltrexone in a Community Treatment Program
Killeen, T. K., Brady, K. T., Gold, P. B., Simpson, K. N., Faldowski, R. A., Tyson, C., & Anton, R. F. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000145688.30448.2c · Cited by 60
Medications and alcohol craving.
Swift, R. M. (1999) · PubMed Central · Cited by 59
Pharmacogenetics of alcohol response and alcoholism: the interplay of genes and environmental factors in thresholds for alcoholism.
Radel, M., & Goldman, D. A. (2001) · PubMed · Cited by 60
Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts
Ferrari, A., Bertolotti, M., Dell'Utri, A., Avico, U., & Sternieri, E. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00098-2 · Cited by 60
Spontaneous and Ethanol‐Stimulated In Vitro Release of β‐Endorphin by the Hypothalamus of AA and ANA Rats
de Waele, J., Kiianmaa, K., & Gianoulakis, C. (1994) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1994.tb01452.x · Cited by 60
The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies
Litten, R. Z., Castle, I. P., Falk, D. E., Ryan, M., Fertig, J. B., Chen, C. M., & Yi, H. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12197 · Cited by 59
Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy
Chen, T. J. H., Blum, K., Payte, J. T., Schoolfield, J. D., Hopper, D., Stanford, M., & Braverman, E. R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.051 · Cited by 59
Suppression of Alcohol Preference by Naltrexone in the Rhesus Macaque: A Critical Role of Genetic Variation at the μ-Opioid Receptor Gene Locus
Barr, C. S., Chen, S. A., Schwandt, M. L., Lindell, S. G., Sun, H., Suomi, S. J., & Heilig, M. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.026 · Cited by 58
Interventions for people with alcohol use disorders and an intellectual disability: A review of the literature
Degenhardt, L. J. (2000) · Journal of Intellectual & Developmental Disability · doi:10.1080/13269780050033553 · Cited by 58
Serum 6-Beta-Naltrexol Levels Are Related to Alcohol Responses in Heavy Drinkers
McCaul, M. E., Wand, G. S., Rohde, C. A., & Lee, S. M. (2000) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2000.tb02107.x · Cited by 59
Alcoholic Patients' Experience and Attitudes on Pharmacotherapy for Alcoholism
Swift, R. M., Duncan, D. F., Nirenberg, T. D., Femino, J., & Femino, J. (1998) · Journal of Addictive Diseases · doi:10.1300/j069v17n03_04 · Cited by 59
Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond
Ciccocioppo, R., Gehlert, D. R., Ryabinin, A. E., Kaur, S., Cippitelli, A., Thorsell, A., Lê, A. D., Hipskind, P. A., Hamdouchi, C., Lu, J., et al. (2009) · Alcohol · doi:10.1016/j.alcohol.2009.08.003 · Cited by 58
Hot or Not: Response Inhibition Reduces the Hedonic Value and Motivational Incentive of Sexual Stimuli
Ferrey, A. E., Frischen, A., & Fenske, M. J. (2012) · Frontiers in Psychology · doi:10.3389/fpsyg.2012.00575 · Cited by 58
Naltrexone-Induced Nausea in Patients Treated for Alcohol Dependence: Clinical Predictors and Evidence for Opioid-Mediated Effects
O’Malley, S. S., Krishnan‐Sarin, S., Farren, C. K., & O’Connor, P. G. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002000-00012 · Cited by 58
Intravenous Self-Administration of Ethanol in beta-Endorphin-Deficient Mice
Grahame, N. J., Low, M. J., & Cunningham, C. L. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199808000-00017 · Cited by 58
Association of Alcohol or Other Drug Dependence with Alleles of the μ Opioid Receptor Gene (OPRM1)
Kranzler, H. R., Gelernter, J. E., O’Malley, S. S., Hernández–Ávila, C. A., & Kaufman, D. L. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03919.x · Cited by 58
Treatment of Cocaine‐Alcohol Dependence with Naltrexone and Relapse Prevention Therapy
Schmitz, J. M., Stotts, A. L., Sayre, S. L., DeLaune, K. A., & Grabowski, J. G. (2004) · American Journal on Addictions · doi:10.1080/10550490490480982 · Cited by 57
Pharmacotherapy of Addictive Disorders
Ross, S., & Peselow, E. D. (2009) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181a91655 · Cited by 57
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol
Ashenhurst, J. R., Bujarski, S., & Ray, L. A. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.08.019 · Cited by 57
Testing Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (The COMBINE Study): A Pilot Feasibility Study
The COMBINE Study Research Group (2003) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000078020.92938.0b · Cited by 57
Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal
Buchhalter, A. R., Fant, R. V., & Henningfield, J. E. (2008) · Drugs · doi:10.2165/00003495-200868080-00005 · Cited by 57
Role of test activity in ethanol-induced disruption of place preference expression in mice
Gremel, C. M., & Cunningham, C. L. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0651-5 · Cited by 57
A Double‐Blind, Placebo‐Controlled Study of Olanzapine in the Treatment of Alcohol‐Dependence Disorder
Guardia, J., Segura, L., Gonzalvo, B., Iglesias, L., Roncero, C., Cardús, M., & Casas, M. (2004) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000125352.06688.f7 · Cited by 57
Naltrexone Effects on Ethanol Drinking Acquisition and on Established Ethanol Consumption in C57BL/6J Mice
Phillips, T. J., Wenger, C. D., & Dorow, J. D. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-199706000-00021 · Cited by 66
Persistent effects of obesity: A neuroplasticity hypothesis
Matikainen‐Ankney, B. A., & Kravitz, A. V. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13665 · Cited by 56
Adoption of naltrexone to treat alcohol dependence.
Fuller, B., Rieckmann, T., McCarty, D., Smith, K. W., & Levine, H. J. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.003 · Cited by 57
Risk factors and outcomes associated with alcohol relapse after liver transplantation
Lim, J. E., Curry, M. P., & Sundaram, V. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i17.771 · Cited by 56
Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism
Krystal, J. H., Madonick, S. H., Perry, E. B., Gueorguieva, R. V., Brush, L., Wray, Y., Belger, A., & D’Souza, D. C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300994 · Cited by 56
Continuing Care
Donovan, D. M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1934-2_23 · Cited by 56
Naloxone facilitates extinction but does not affect acquisition or expression of ethanol-induced conditioned place preference.
Cunningham, C. L., Dickinson, S. D., & Okorn, D. M. (1995) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.3.4.330 · Cited by 56
RETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents
Niederhofer, H., & Staffen, W. (2003) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-003-0327-1 · Cited by 55
Retracted
Attenuation of cocaine and heroin seeking by μ-opioid receptor antagonism
Giuliano, C., Robbins, T. W., Willé, D. R., Bullmore, E. T., & Everitt, B. J. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2949-9 · Cited by 55
Treatment Issues Pertaining to Pathological Gamblers with a Comorbid Disorder
Winters, K. C., & Kushner, M. G. (2003) · Journal of Gambling Studies · doi:10.1023/a:1024203403982 · Cited by 55
Ethanol Disinhibits Dorsolateral Striatal Medium Spiny Neurons Through Activation of A Presynaptic Delta Opioid Receptor
Patton, M. H., Roberts, B. M., Lovinger, D. M., & Mathur, B. N. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.353 · Cited by 55
Alcohol-Related Disorders
Kelly, J. F., & Renner, J. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50028-7 · Cited by 55
Comparison of the Proopiomelanocortin and Proenkephalin Opioid Peptide Systems in Brain Regions of the Alcohol-Preferring C57BL/6 and Alcohol-Avoiding DBA/2 Mice
Jamensky, N. T., & Gianoulakis, C. (1999) · Alcohol · doi:10.1016/s0741-8329(99)00002-6 · Cited by 55
Choosing a behavioral therapy platform for pharmacotherapy of substance users
Carroll, K. M., Kosten, T. R., & Rounsaville, B. J. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.007 · Cited by 58
Traditional and Western Healing Practices for Alcoholism in American Indians and Alaska Natives
Abbott, P. J. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059342 · Cited by 55
The Opioid Receptor Antagonist Nalmefene Reduces Responding Maintained by Ethanol Presentation: Preclinical Studies in Ethanol‐Preferring and Outbred Wistar Rats
June, H. L., Grey, C., Warren‐Reese, C., Durr, L. F., Ricks‐Cord, A., Johnson, A., McCane, S., Williams, L., Mason, D., Cummings, R., et al. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb05931.x · Cited by 55
Suppression of Alcohol Intake by Chronic Naloxone Treatment in P Rats: Tolerance Development and Elevation of Opiate Receptor Binding
Overstreet, D. H., Kampov‐Polevoy, A. B., Rezvani, A. H., Braun, C., Bartus, R. T., & Crews, F. T. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04071.x · Cited by 55
COMBINATION PHARMACOTHERAPY: A MIXTURE OF SMALL DOSES OF NALTREXONE, FLUOXETINE, AND A THYROTROPIN-RELEASING HORMONE ANALOGUE REDUCES ALCOHOL INTAKE IN THREE STRAINS OF ALCOHOL-PREFERRING RATS
Rezvani, A. H. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.1.76 · Cited by 55
Effect of Naloxone on Appetitive and Consummatory Phases of Ethanol Self-Administration
Sharpe, A. L., & Samson, H. H. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02309.x · Cited by 55
Endogenous opiates: 1992
Olson, G. A., Olson, R. D., & Kastin, A. J. (1993) · Peptides · doi:10.1016/0196-9781(93)90195-m · Cited by 55
Alcohol reinforcement and neuropharmacological therapeutics
LEWIS, M. J. (1996) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008214 · Cited by 54
Morphine alkaloids: History, biology, and synthesis
Wicks, C., Hudlický, T., & Rinner, U. (2021) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/bs.alkal.2021.04.001 · Cited by 54
Sweet Liking Phenotype, Alcohol Craving and Response to Naltrexone Treatment in Alcohol Dependence
Garbutt, J. C., Osborne, M., Gallop, R., Barkenbus, J., Grace, K., Cody, M. W., Flannery, B., & Kampov‐Polevoy, A. B. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn122 · Cited by 52
Naltrexone reduces ethanol- and sucrose-reinforced responding in rhesus monkeys
Williams, K. L., Winger, G. D., Pakarinen, E. D., & Woods, J. H. (1998) · Psychopharmacology · doi:10.1007/s002130050689 · Cited by 54
Carbohydrate‐Deficient Transferrin as an Indicator of Drinking Status During a Treatment Outcome Study
Anton, R. F., Moak, D. H., & Latham, P. K. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb05261.x · Cited by 54
Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats
Czachowski, C. L., & DeLory, M. J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1465-z · Cited by 53
Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers
Comer, S. D., Mogali, S., Saccone, P. A., Askalsky, P., Martínez, D., Walker, E. A., Jones, J. D., Vosburg, S. K., Cooper, Z. D., Roux, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.143 · Cited by 52
Treatment of Sleep Disturbance in Alcohol Recovery
Friedmann, P. D., Herman, D. S., Freedman, S., Lemon, S. C., Ramsey, S. E., & Stein, M. D. (2003) · Journal of Addictive Diseases · doi:10.1300/j069v22n02_08 · Cited by 53
Differences in the Opioid System in Selected Brain Regions of Alcohol-Preferring and Alcohol-Nonpreferring Rats
Fadda, P., Tronci, S., Colombo, G., & Fratta, W. (1999) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04350.x · Cited by 51
Comorbidity issues in the pharmacological treatment of Pathological Gambling: a critical review.
Dell’Osso, B. M., Allen, A., & Hollander, E. (2005) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-1-21 · Cited by 53
Naltrexone alters the processing of social and emotional stimuli in healthy adults
Wardle, M. C., Bershad, A. K., & de Wit, H. (2015) · Social Neuroscience · doi:10.1080/17470919.2015.1136355 · Cited by 52
Naltrexone Suppresses Ethanol Intake in 6-Hydroxydopamine???Treated Rats
Koistinen, M., Tuomainen, P. M., Hyytiä, P., & Kiianmaa, K. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200111000-00008 · Cited by 55
An Open-Label Pilot Study of Naltrexone in Childhood-Onset Trichotillomania
Sousa, A. D. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0111 · Cited by 53
Preclinical and clinical pharmacology of alcohol dependence
Tambour, S., & Quertemont, É. (2006) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00459.x · Cited by 53
The Neurobiology of Ethanol‐Opioid Interactions in Ethanol Reinforcement
Froehlich, J. C., & Wand, G. S. (1996) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01772.x · Cited by 53
Effect of Ethanol, Propanol, Butanol, and Catalase Enzyme Blockers on β‐Endorphin Secretion from Primary Cultures of Hypothalamic Neurons: Evidence for a Mediatory Role of Acetaldehyde in Ethanol Stimulation of β‐Endorphin Release
Reddy, B. V., Boyadjieva, N. I., & Sarkar, D. K. (1995) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1995.tb01512.x · Cited by 53
Characterization of the ?? and delta Opioid Receptors in the Brain of the C57BL/6 and DBA/2 Mice, Selected for Their Differences in Voluntary Ethanol Consumption
de Waele, J., & Gianoulakis, C. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03834.x · Cited by 53
From Disordered Eating to Addiction: The “Food Drug” in Bulimia Nervosa
Umberg, E. N., Shader, R. I., Hsu, L. K. G., & Greenblatt, D. J. (2012) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318252464f · Cited by 52
Alcohol research: past, present, and future
Gunzerath, L., Hewitt, B. G., Li, T., & Warren, K. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05832.x · Cited by 55
Emerging pharmacotherapies for alcohol dependence: A systematic review focusing on reduction in consumption
Aubin, H., & Daeppen, J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.025 · Cited by 52
Medication Compliance During a Smoking Cessation Clinical Trial: A Brief Intervention Using MEMS Feedback
Schmitz, J. M., Sayre, S. L., Stotts, A. L., Rothfleisch, J., & Mooney, M. E. (2005) · Journal of Behavioral Medicine · doi:10.1007/s10865-005-3663-4 · Cited by 54
Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians
Ehlers, C. L., Lind, P. A., & Wilhelmsen, K. C. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-35 · Cited by 53
Acute ethanol induction of c-Fos immunoreactivity in pre-pro-enkephalin expressing neurons of the central nucleus of the amygdala
Criado, J. R., & Morales, M. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02468-3 · Cited by 52
Differences in the Peripheral Levels of ??-endorphin in Response to Alcohol and Stress as a Function of Alcohol Dependence and Family History of Alcoholism
Dai, X., Thavundayil, J., & Gianoulakis, C. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000187599.17786.4a · Cited by 52
Hepatic Safety of Once‐Monthly Injectable Extended‐Release Naltrexone Administered to Actively Drinking Alcoholics
Lucey, M. R., Silverman, B. L., Illeperuma, A., & O’Brien, C. P. (2008) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00593.x · Cited by 52
The Treatment of Addiction: What Can Research Offer Practice?
Lamb, S., Greenlick, M. R., & McCarty, D. W. (1998) · Cited by 52
Brain Reward Circuits in Alcoholism
Koob, G. F., & Roberts, A. J. (1999) · CNS Spectrums · doi:10.1017/s1092852900011196 · Cited by 51
Naltrexone Treatment Increases the Aversiveness of Alcohol for Outbred Rats
Hill, K., & Kiefer, S. W. (1997) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1997.tb03815.x · Cited by 52
The past and future of research on treatment of alcohol dependence.
Willenbring, M. L. (2010) · Europe PMC (PubMed Central) · Cited by 51
A categorical typology of naltrexone-adopting private substance abuse treatment centers
Oser, C. B., & Roman, P. M. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.08.003 · Cited by 51
Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking
Tanchuck, M. A., Yoneyama, N., Ford, M. M., Fretwell, A. M., & Finn, D. A. (2010) · Alcohol · doi:10.1016/j.alcohol.2010.07.009 · Cited by 51
Practitioner Review: Adolescent alcohol use disorders: assessment and treatment issues
Perepletchikova, F., Krystal, J. H., & Kaufman, J. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01934.x · Cited by 55
Adrenocorticotropin Responses to Naloxone in Sons of Alcohol-Dependent Men
Wand, G. S., Mangold, D. L., & Ali, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5373 · Cited by 52
Effects of Acute and Chronic Doses of Naltrexone on Ethanol Self-Administration in Rhesus Monkeys
Boyle, A. E., Stewart, R. B., Macenski, M. J., Spiga, R., Johnson, B. A., & Meisch, R. A. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03661.x · Cited by 51
TRAIT MARKERS FOR ALCOHOLISM: CLINICAL UTILITY
Farren, C. K. (1999) · Alcohol and Alcoholism · doi:10.1093/alcalc/34.5.649 · Cited by 51
The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat
Stromberg, M. F., Mackler, S. A., Volpicelli, J. R., O’Brien, C. P., & Dewey, S. L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00456-1 · Cited by 51
Self-citation
The role of craving in AUDs: Dimensionality and Differential Functioning in the DSM-5
Casey, M., Adamson, G., Shevlin, M. E., & McKinney, A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.019 · Cited by 50
The Associations between Self-Consciousness, Depressive State and Craving to Drink among Alcohol Dependent Patients Undergoing Protracted Withdrawal
de Timary, P., Uva, M. C. D. S., Denoël, C., Hebborn, L. F., Derely, M., Desseilles, M., & Luminet, O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071560 · Cited by 50
From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy
Richerson, G. B., Boison, D., Faingold, C. L., & Ryvlin, P. (2016) · Epilepsia · doi:10.1111/epi.13236 · Cited by 51
Drug addiction as a physical disease: The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
Lyvers, M. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.1.107 · Cited by 51
Use of Naltrexone in the Treatment of Alcohol Use Disorders in Patients with Concomitant Major Mental Illness
Maxwell, S., & Shinderman, M. S. (2000) · Journal of Addictive Diseases · doi:10.1300/j069v19n03_05 · Cited by 50
New drug treatments for alcohol problems: a critical appraisal
Moncrieff, J., & Drummond, C. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02966.x · Cited by 49
Why Alcoholism Is a Disease
Maltzman, I. M. (1994) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1994.10472598 · Cited by 50

Authors: Volpicelli, J. R.
Affiliations: University of Pennsylvania (US)
Corresponding author: Volpicelli, Joseph R.
ORCID: Volpicelli, Joseph R.
Venue: Archives of General Psychiatry
Publisher: American Medical Association (AMA)
Published: 1992-11-01
Volume: 49
Issue: 11
Pages: 876
ISSN: 0003-990X (ISSN-L)
DOI: 10.1001/archpsyc.1992.01820110040006
OpenAlex: W2104538950
Cited by: 1,828
References: 23
Citations by year: 2026: 7 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 25 · 2021: 17 · 2020: 28 · 2019: 26 · 2018: 29 · 2017: 26 · 2016: 32 · 2015: 48 · 2014: 49 · 2013: 47 · 2012: 58
FWCI: 36.57
Type: journal article
Language: en
Open access: closed
Locations: Archives of General Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Alcohol Abuse and Alcoholism (AA0751701A1)
National Institute on Drug Abuse (DA-05186)
Topics: Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords: naltrexone, alcoholism, alcohol craving, alcohol relapse prevention, alcohol detoxification, outpatient care, opioid antagonists, adjunct pharmacotherapy, nausea, arthritic pain
MeSH terms: Adult, Alcohol Drinking, Alcoholism, Ambulatory Care, Combined Modality Therapy, Double-Blind Method, Humans, Male, Naltrexone, Nausea, Patient Dropouts, Placebos, Psychiatric Status Rating Scales, Psychotherapy, Recurrence, Severity of Illness Index, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Naltrexone in the Treatment of Alcohol Dependence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks